Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0001567619-22-021571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-14 | 2022-12-12 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $1.20 | +3,000 | 911.7K | +0.3% | +$3,600 |
| DI | 2022-12-14 | 2022-12-13 | TXG | Saxonov Serge | CEO, Dir | G - Gift | $0.00 | -1,740 | 747 | -70% | $0 |
| D | 2022-12-14 | 2022-12-12 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -3,000 | 38.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-12 | M | A | 3,000 | $1.20 | 911,656 | D See footnote | — | — | (F1) Excludes 870 shares transferred to Sirius Trust, 9,400 shares transferred to Y/S Pot Trust and 56,000 shares transferred to the Y/S Descendants' Trust, on December 13, 2022. (F2) The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee. |
| 2 | Common | Class A Common Stock | 2022-12-13 | G | D | 1,740 | $0.00 | 747 | I | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2022-12-12 | M | D | 3,000 | $0.00 | 38,035 | D | $1.20 · — to 2027-10-18 | 3,000 Class A Common Stock | (F6) This option, originally for 300,000 shares, of which 261,965 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |